Literature DB >> 8640344

Reflex circulatory collapse following intrapulmonary entrapment of activated platelets: mediation via 5-HT3 receptor stimulation.

O L Leaños1, E Hong, J L Amezcua.   

Abstract

1. The role of 5-HT2 and 5-HT3 receptors in the mediation of direct and reflex vascular responses to intrapulmonary platelet activation was investigated. 2. Anaesthetized rabbits were challenged intravenously with an emulsion of autologous bone marrow that produced a sharp increase in pulmonary blood pressure, a fall in systemic blood pressure, platelet consumption and death. 3. Platelet depletion before the challenge nearly abolished all the cardiovascular effects and prevented death. Bilateral vagotomy prevented the fall in systemic blood pressure and death but did no prevent the increase in pulmonary pressure. The intravenous administration of the 5-HT2 antagonist, ketanserin, only reduced the increase in pulmonary pressure without affecting the systemic response or mortality. 4. The effects of intravenous 5-HT and of electrical stimulation of the cephalic ends of the cut vagi nerves were also explored. 5-HT injection increased the pulmonary vascular pressure but its effects on systemic blood pressure were variable. These response were modified by the 5-HT antagonists in a manner that resembles their effects on bone marrow embolism. Afferent vagal stimulation produced a fall in systemic blood pressure that was not prevented by MDL-7222. 5. This study indicates that a centrally mediated reduction of peripheral vascular tone is the cause of the potentially lethal circulatory collapse that follows the intrapulmonary entrapment of activated platelets. This reflex is initiated by the action of 5-HT on 5-HT3 receptors in the lung.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8640344      PMCID: PMC1908951          DOI: 10.1111/j.1476-5381.1995.tb16410.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  19 in total

1.  THE ROLE OF MICRO-EMBOLISM IN THE PRODUCTION OF IRREVERSIBLE SHOCK.

Authors:  H J ROBB
Journal:  Ann Surg       Date:  1963-10       Impact factor: 12.969

2.  Fat emboli syndrome.

Authors:  J A Moylan; M Birnbaum; A Katz; M A Everson
Journal:  J Trauma       Date:  1976-05

Review 3.  Role of cardiac vagal C-fibers in cardiovascular control.

Authors:  P Thorén
Journal:  Rev Physiol Biochem Pharmacol       Date:  1979       Impact factor: 5.545

4.  Pulmonary entrapment of platelets during acute respiratory failure.

Authors:  H B Hechtman; E A Lonergan; H P Staunton; R C Dennis; D Shepro
Journal:  Surgery       Date:  1978-03       Impact factor: 3.982

5.  Humoral factors in massive pulmonary embolism: an experimental study.

Authors:  V Gurewich; M L Cohen; D P Thomas
Journal:  Am Heart J       Date:  1968-12       Impact factor: 4.749

Review 6.  Trends in microvascular research. The microembolism syndrome.

Authors:  T Saldeen
Journal:  Microvasc Res       Date:  1976-03       Impact factor: 3.514

7.  Intravascular platelet aggregation and pulmonary injury.

Authors:  J Vaage
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

Review 8.  Fat embolism syndrome: a review of the pathophysiology and physiological basis of treatment.

Authors:  H R Gossling; V D Pellegrini
Journal:  Clin Orthop Relat Res       Date:  1982-05       Impact factor: 4.176

9.  Vasoconstrictor effect of thromboxane A2.

Authors:  J Svensson; B B Fredholm
Journal:  Acta Physiol Scand       Date:  1977-11

10.  Analysis of 96 abnormal brain scans using technetium 99m (pertechnetate form).

Authors:  J L Quinn; I Ciric; W N Hauser
Journal:  JAMA       Date:  1965-10-11       Impact factor: 56.272

View more
  3 in total

1.  Bimodality of cardiac vagal afferent C-fibres in the rat.

Authors:  Roland Veelken; Alexander Stetter; Tobias Dickel; Karl F Hilgers
Journal:  Pflugers Arch       Date:  2003-04-15       Impact factor: 3.657

2.  Atypical Amniotic Fluid Embolism Managed with a Novel Therapeutic Regimen.

Authors:  Shadi Rezai; Alexander C Hughes; Tracy B Larsen; Paul N Fuller; Cassandra E Henderson
Journal:  Case Rep Obstet Gynecol       Date:  2017-12-21

3.  Atropine, Ondansetron, and Ketorolac: Supplemental Management of Amniotic Fluid Embolism.

Authors:  Miranda Long; Jane Martin; Joseph Biggio
Journal:  Ochsner J       Date:  2022
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.